Jordan Ellis
Memorial Sloan Kettering, also known as Memorial Sloan Kettering Cancer Center (MSK), is a cancer treatment and research institution in Manhattan, New York City. It was formed in 1980 from the merger of the Memorial Hospital for the Treatment of Cancer and Allied Diseases, founded in 1884, and the adjacent Sloan-Kettering Institute for Cancer Research, founded in 1945. The hospital has been recognised as one of the nation's premier hospitals for cancer treatment, research, and education. It offers a wide range of programs to support people with cancer and their families throughout all phases of treatment. With its high degree of specialisation, MSK's doctors treat hundreds of cancer subtypes and are involved in numerous clinical trials. The institution also prioritises education, with training programs that prepare future doctors, scientists, and healthcare professionals for leadership roles.
| Characteristics | Values |
|---|---|
| Name | Memorial Sloan Kettering Cancer Center (MSK) |
| Type | Cancer treatment and research institution |
| Location | Manhattan, New York City |
| Address | 1275 York Avenue between 67th and 68th Streets in Manhattan |
| History | Formed in 1980 from the merger of Memorial Hospital for the Treatment of Cancer and Allied Diseases (founded in 1884) and the Sloan-Kettering Institute for Cancer Research (founded in 1945) |
| Departments | Pediatrics, Integrative Medicine, Image-Guided Intervention, Rehabilitation, Proton Therapy, Oncology |
| Recognition | Ranked as the number two hospital for cancer care in the U.S. by U.S. News & World Report; Recognized for groundbreaking contributions in cancer treatment and research |
| Education | Gerstner Sloan Kettering Graduate School of Biomedical Sciences offering a Ph.D. in cancer biology; Training programs for the next generation of doctors, scientists, and healthcare professionals |
| Staff | More than 20,000 physicians, scientists, nurses, and staff |
| Notable Figures | William B. Coley (pioneer of early immunotherapy); John Heller (former director of NCI); Harold Varmus (former NIH director) |
| Patients | Cancer patients, including pediatric and adult patients |
| Services | Support groups, genetic counseling, pain management, rehabilitation, integrative medicine, financial toxicity support |
| Partnerships | Amgen (agreement for royalties on recombinant granulocyte colony-stimulating factor); New York Proton Center (in partnership with Montefiore Health and Mount Sinai Health System) |
Explore related products
What You'll Learn
Memorial Sloan Kettering Cancer Center (MSK)
MSK was formed in 1980 from the merger of the Memorial Hospital for the Treatment of Cancer and Allied Diseases, founded in 1884, and the adjacent Sloan-Kettering Institute for Cancer Research, founded in 1945. The two medical entities had formally coordinated their operations since 1960. The hospital was founded in its original building on the Upper West Side of Manhattan in 1884 as the New York Cancer Hospital by a group that included John Jacob Astor III and his wife Charlotte.
The Memorial Sloan Kettering Bendheim Integrative Medicine Center is a stand-alone outpatient facility developed from the Integrative Medicine Service that began in 1999. The Center for Image-Guided Intervention was opened in June 2010 in the Memorial Hospital building to oversee image-guiding activities across MSK. In October 2012, the Sillerman Center for Rehabilitation was opened, moving rehabilitation out of Memorial Hospital and closer to the Rockefeller Outpatient Pavilion. The New York Proton Center, the first proton therapy center in New York state, opened in 2019 as a partnership between MSK, Montefiore Health, and Mount Sinai Health System.
MSK offers a full range of programs to help people with cancer and their families throughout all phases of treatment, including support groups, genetic counselling, help in managing pain and symptoms, rehabilitation, and assistance in navigating life after treatment. MSK also offers influential educational programs, with a series of training programs preparing the next generation of doctors, scientists, and healthcare professionals for leadership roles in the life sciences and medicine. The Department of Pediatrics at MSK makes school a high priority, with several full-time teachers who play an active role in delivering complete care to pediatric patients.
MSK has pioneered many treatment advances over the years, including radiation therapy, chemotherapy, immunotherapy, and precision medicine. Its doctors are currently leading hundreds of clinical trials for pediatric and adult cancers, and its scientists are making progress in understanding the biology of cancer through research programs in cancer biology and genetics, cell biology, computational biology, developmental biology, immunology, molecular biology, molecular pharmacology, chemical biology, and structural biology.
Hospitals Testing for Delta Variant: What You Need to Know
You may want to see also
Explore related products
MSK's commitment to patient care, research and education
Memorial Sloan Kettering Cancer Center (MSK) is a renowned institution with a steadfast commitment to patient care, research, and education. Its dedicated professionals strive to end cancer and provide the best possible care to patients of all ages. MSK's specialised care teams offer personalised and compassionate care, informed by groundbreaking research from the Sloan Kettering Institute.
In terms of patient care, MSK excels in providing comprehensive support to patients and their families throughout all phases of treatment and beyond. Their programs include support groups, genetic counselling, pain and symptom management, rehabilitation, and integrative medical services. MSK also prioritises education, with initiatives like the Hospital Schools program, where full-time teachers work alongside medical staff to provide continuity of education for paediatric patients. This helps children and teens maintain a sense of normalcy during treatment and keep up with their peers academically.
MSK's commitment to research is evident in their innovative collaborations across the healthcare industry. Their scientists conduct translational and clinical research, enhancing our understanding of cancer and improving prevention, diagnosis, and treatment methods. This research has led to the establishment of standards of care and treatment protocols for each type and stage of cancer, benefiting patients worldwide.
Additionally, MSK is dedicated to education and training the next generation of healthcare professionals. They offer a range of training programs that prepare future doctors, scientists, and healthcare leaders. The Gerstner Sloan Kettering Graduate School of Biomedical Sciences, established in 2004, provides a Ph.D. degree in cancer biology, contributing to the advancement of cancer research and treatment.
MSK's commitment to patient care, research, and education is further exemplified by their pursuit of inclusivity and diversity. They actively collaborate and share their resources with community partners to improve cancer care and eliminate health disparities, ensuring that their advancements benefit people from all walks of life.
Mather Hospital: Psychiatric Unit Availability and Services
You may want to see also
Explore related products
MSK's training programs for future doctors, scientists and healthcare professionals
Memorial Sloan Kettering Cancer Center (MSK) is a cancer treatment and research institution in Manhattan, New York City. It was formed in 1980 from the merger of the Memorial Hospital for the Treatment of Cancer and Allied Diseases and the Sloan-Kettering Institute for Cancer Research.
MSK offers a range of training programs for future doctors, scientists, and healthcare professionals. One of these is the Gerstner Sloan Kettering Graduate School of Biomedical Sciences, which was established in 2004 and offers a Ph.D. degree in cancer biology. The program aims to prepare graduates to be leaders in clinical medicine and scientific research, impacting the future of medicine and science. The curriculum is flexible, giving students the freedom to pursue their interests and become the physician-scientists they want to be.
Additionally, MSK offers a full range of programs to support people with cancer and their families throughout all phases of treatment, including support groups, genetic counselling, pain and symptom management, rehabilitation, and integrative medical services. These programs provide valuable learning opportunities for healthcare professionals and future doctors, offering insight into the patient experience and the practical application of medical knowledge.
MSK also has a strong focus on research. Its scientists are engaged in various research programs, including cancer biology and genetics, cell biology, computational biology, developmental biology, immunology, molecular biology, molecular pharmacology, chemical biology, and structural biology. Through its Human Oncology and Pathogenesis Program, MSK also bridges the gap between laboratory research and clinical practice.
Furthermore, MSK is committed to education and has established standards of care and treatment protocols for each type and stage of cancer. Its doctors work closely with scientists to ensure that patient care, research, and education are all given priority. MSK was one of the first cancer centres to receive the Comprehensive Cancer Center designation from the NCI in 1971, recognising its expertise and contribution to the field.
Dental Hospital Walk-Ins: Are They Possible?
You may want to see also
Explore related products
![The Hospital [DVD]](https://m.media-amazon.com/images/I/61oQ2sBPcmL._AC_UY218_.jpg)
MSK's history and establishment
Memorial Sloan Kettering (MSK) is a world-leading cancer treatment and research institution in Manhattan, New York City. The centre was formed in 1980 from the merger of the Memorial Hospital for the Treatment of Cancer and Allied Diseases and the Sloan-Kettering Institute for Cancer Research, founded in 1884 and 1945, respectively.
The Memorial Hospital was founded in 1884 as the New York Cancer Hospital by a group that included John Jacob Astor III and his wife, Charlotte. The hospital was originally located on the Upper West Side of Manhattan. John D. Rockefeller Jr. donated land on York Avenue for a new location in 1934, and the Memorial Hospital officially reopened at this new site in 1939.
The Sloan-Kettering Institute for Cancer Research was founded through a $4 million donation from the chairman of General Motors, Alfred P. Sloan, in 1945. The Sloan-Kettering Institute was built adjacent to the Memorial Hospital and was formally dedicated in 1948.
In 1960, a new corporate entity, the Memorial Sloan Kettering Cancer Center, was formed to coordinate and guide the overall policy for the Memorial Hospital and the Sloan-Kettering Institute. In the same year, John Heller, the former director of the National Cancer Institute, was named its president. At the end of the 1960s, the Memorial Sloan Kettering Cancer Center opened an outpatient paediatric day hospital, partly to deal with the growing number of cancer survivors.
In 1980, the Memorial Hospital and the Sloan-Kettering Institute formally merged into a single entity under the name Memorial Sloan Kettering Cancer Center, with a single president and CEO. The centre has since continued to expand its outpatient facilities and services to meet the growing needs of its patients, physicians, and researchers.
The Lawsuit Fiasco: Pelosi vs. Sanford Hospital
You may want to see also
Explore related products
MSK's ranking as one of the best hospitals for cancer care
Memorial Sloan Kettering Cancer Center (MSK) is a cancer treatment and research institution in Manhattan, New York City. It was formed in 1980 from the merger of the Memorial Hospital for the Treatment of Cancer and Allied Diseases and the Sloan-Kettering Institute for Cancer Research.
MSK has consistently been ranked as one of the top hospitals for cancer care in the United States. For 35 years, U.S. News & World Report has recognized MSK as a "best hospital" for cancer care. In its annual Best Hospitals list, U.S. News & World Report ranked MSK as the best cancer center in the Northeast, the second-best cancer hospital in the nation, and the top hospital for urology care. Additionally, MSK has been designated as one of 72 National Cancer Institute–designated Comprehensive Cancer Centers.
MSK's expertise in cancer care is well-known, and its staff is dedicated and compassionate. The institution offers a full range of programs to support people with cancer and their families throughout all phases of treatment, including support groups, genetic counseling, pain and symptom management, rehabilitation, and integrative medical services. MSK also provides assistance in navigating life after treatment.
MSK has pioneered many treatment advances over the years, including radiation therapy, chemotherapy, immunotherapy, and precision medicine. Its doctors are currently leading hundreds of clinical trials for pediatric and adult cancers, and its scientists are making significant progress in understanding the biology of cancer through various research programs. MSK's Gerstner Sloan Kettering Graduate School of Biomedical Sciences, established in 2004, offers a Ph.D. degree in cancer biology.
The institution has also established several centers and facilities dedicated to cancer care and research, such as the Bendheim Integrative Medicine Center, the Center for Image-Guided Intervention, the Sillerman Center for Rehabilitation, and the David H. Koch Center for Cancer Care.
Barbados Hospitals: World-Class Care and Service
You may want to see also
Frequently asked questions
Yes, Memorial Sloan Kettering is a teaching hospital. It was formed in 1980 from the merger of the Memorial Hospital for the Treatment of Cancer and Allied Diseases, founded in 1884, and the Sloan-Kettering Institute for Cancer Research, founded in 1945. The Memorial Sloan Kettering Bendheim Integrative Medicine Center is a stand-alone outpatient facility that began in 1999. The hospital also has a Gerstner Sloan Kettering Graduate School of Biomedical Sciences, established in 2004, which offers a Ph.D. degree in cancer biology.
Memorial Sloan Kettering Cancer Center (MSK) is one of the oldest and largest private cancer centres in the world. It was founded in 1884 as the New York Cancer Hospital by a group that included John Jacob Astor III and his wife Charlotte. The hospital was originally located on the Upper West Side of Manhattan. In 1939, it moved to a new facility on land donated by John D. Rockefeller Jr. and was renamed the Memorial Hospital for the Treatment of Cancer and Allied Diseases.
Memorial Sloan Kettering is committed to advancing patient care, groundbreaking research, clinical treatment advances, and cancer prevention advocacy. The centre has been recognised as one of the top hospitals for cancer care and research in the United States.
Memorial Sloan Kettering has pioneered many treatment advances, including radiation therapy, chemotherapy, immunotherapy, and precision medicine. The hospital has also been recognised for making groundbreaking contributions, such as redefining standard treatments for breast cancer patients and pioneering the use of mRNA vaccines as a pancreatic cancer treatment.
